Fri, December 1, 2023

Aydin Huseynov Upgraded (ALRN) to Strong Buy and Held Target at $9 on, Dec 1st, 2023

Aydin Huseynov of Ladenburg Thalmann, Upgraded "Aileron Therapeutics, Inc." (ALRN) to Strong Buy and Held Target at $9 on, Dec 1st, 2023.

Aydin, nor any peers, have made any analyst calls on ALRN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30